# Reinhard Büttner

Source: https://onco.cc/people/reinhard-buettner/  
OnCo record `reinhard-buettner` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Molecular pathologist who co-founded Network Genomic Medicine and characterised lung cancer genomes.

## Summary

Reinhard Büttner is Director of the Institute of Pathology at University Hospital Cologne (CIO). A molecular pathologist, his specialisms are molecular pathology, lung cancer genomics and predictive biomarkers, combining histopathology and immunohistochemistry with comprehensive genomic profiling. He co-founded Network Genomic Medicine and co-authored the Clinical Lung Cancer Genome Project analyses that defined targetable alterations in non-small-cell lung cancer. His papers include a review of PD-L1 immunohistochemistry assays and their clinical implementation in lung cancer, a study of KEAP1- and NFE2L2-mutated non-small-cell lung carcinoma, and a review of precision medicine in non-small-cell lung cancer. His publications are listed on PubMed.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Director, Institute of Pathology, University Hospital Cologne
- Specialisms: Molecular pathology; Lung cancer genomics; Predictive biomarkers

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Buttner%20R%5BAuthor%5D%20lung%20cancer%20genome

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Comprehensive genomic profiling](https://onco.cc/technologies/cgp/), [Histopathology & immunohistochemistry](https://onco.cc/technologies/histopathology-ihc/)
- institutions: [nationales Netzwerk Genomische Medizin Lungenkrebs](https://onco.cc/institutions/nngm/), [Uniklinik Köln (CIO)](https://onco.cc/institutions/uniklinik-koeln/)
- journals: [Seminars in cancer biology](https://onco.cc/journals/seminars-in-cancer-biology/)

---
JSON: https://onco.cc/api/v1/entities/reinhard-buettner.json